To examine whether response to first treatment with onabotulinumtoxinA is predictive of long‐term treatment outcome in patients with neurogenic detrusor overactivity (NDO). Click to show full abstract
To examine whether response to first treatment with onabotulinumtoxinA is predictive of long‐term treatment outcome in patients with neurogenic detrusor overactivity (NDO).
               
Click one of the above tabs to view related content.